Honored to present our 25-year scientometric analysis of robotic urology at #ERUS26! 🌍🤖
Mapped 12k+ papers (2000-2025):
• 🇺🇸 US leads total volume, with 🇮🇹 Italy as the secondary global hub
• Major output from @harvardmed , @CleClinicUro , @SanRaffaeleMI and @HenryFordHealth
• Dense international clusters around pioneers like Prof. F. Porpiglia & Prof @ricautor
• Uro-oncology remains the primary driver of growth
@Uroweb@ERUSrobotics
For short (<3 cm) bulbar strictures recurring after ≥2 endoscopic treatments, consider drug-coated balloon dilatation (paclitaxel):
📊 ROBUST-3: 6-mo patency 75% vs 27%, 1-yr retreatment-free 83% vs 22%
🔒 For those unfit for urethroplasty
#Strictures#EAUGuidelines
🚀 New publication!
“Magnetic sentinel node biopsy with Sienna+®/SentiMag® in penile SCC” — a radiation-free, practical alternative for sentinel node biopsy, already validated in breast cancer & melanoma.
Published in Urology Case Reports.
🔗 https://t.co/jvYnO2S7BM
Yesterday at the “Curso de Escrita de Artigos de Investigação Clínica, com apoio da IA”, organized by GAPIC at Faculdade de Medicina da Universidade de Lisboa
Always good to be back home!
Excited to share my review on the Optilume: https://t.co/HDHzjvLbTQ
While not curative, it may delay the need for frequent endoscopic interventions, improve quality of life, and certainly has a promising role in the future management of urethral stricture disease 💡
Joined a beach volleyball tournament today with longtime friends. It once was our full-time job — now it’s the perfect way to disconnect, recharge, and have fun outside of work.
Excited to be back at the #AIMSMeeting , this time as a workshop instructor on Urologic Emergencies! 🚑
Having been a member and Scientific Department coordinator in the past, this project holds a special place for me. Honored to contribute once again!
🔎 4-year results from ROBUST III presented at #EAU25!
✅ 68.5% freedom from reintervention at 4y!
✅ IPSS improvements remain stable long-term
📉Qmax a slow downward trajectory but still outperforming other treatments
Promising durability for Optilume! 💡@OptilumeDCB@Uroweb
🚀 #EAU25@PierreFabre Symposium:
📌 Clinical exam may help uncover OAB → better treatment
📌 One size fits all ?✖️- tailor treatment!
📌 Shared decision making is 🔑 - put the patient first
📌 OAB phenotyping is achievable and we’re getting closer!
@BPeyronnet@Uroweb
Experts vs #AI in analysing clinical cases at today’s #simposioAPU 🇵🇹
While promising, AI still lacks the nuance and clinical judgement that human experience provides!
#APU#Urologia@apurologia
🔍✨ New #ProstateCancer study unveils updated #PRECISE recommendations for MRI in active surveillance. Key findings:
✅ Standardized image quality is vital
🖥️Comparison with baseline and previous scans essential
📈Clarifications on lesion measurement and progression criteria
These guidelines offer crucial insights into enhancing MRI reporting in AS patients #MedicalResearch
https://t.co/Y8akmyKcwV